Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114898234 | 11489823 | 4 | F | 20150822 | 20160822 | 20150910 | 20160824 | EXP | JP-GLAXOSMITHKLINE-JP2015JPN127638 | GLAXOSMITHKLINE | 65.30 | YR | F | Y | 68.00000 | KG | 20160824 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114898234 | 11489823 | 1 | PS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 25 MG, QD | Y | 20241 | 25 | MG | TABLET | QD | |||||
| 114898234 | 11489823 | 2 | SS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 50 MG, QD | Y | 20241 | 50 | MG | TABLET | QD | |||||
| 114898234 | 11489823 | 3 | SS | ETHYL ICOSAPENTATE | ICOSAPENT ETHYL | 1 | Oral | 900 MG, QD | 0 | 900 | MG | QD | |||||||
| 114898234 | 11489823 | 4 | SS | PRAVASTATIN NA | PRAVASTATIN SODIUM | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 114898234 | 11489823 | 5 | C | LITHIUM CARBONATE. | LITHIUM CARBONATE | 1 | 200 MG, TID | 0 | 200 | MG | TID | ||||||||
| 114898234 | 11489823 | 6 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | 10 MG, QD | 0 | 10 | MG | QD | ||||||||
| 114898234 | 11489823 | 7 | C | ZYPREXA | OLANZAPINE | 1 | 5 MG, QD | 0 | 5 | MG | QD | ||||||||
| 114898234 | 11489823 | 8 | C | FLUNITRAZEPAM | FLUNITRAZEPAM | 1 | 1 MG, QD | 0 | 1 | MG | QD | ||||||||
| 114898234 | 11489823 | 9 | C | TAMBOCOR | FLECAINIDE ACETATE | 1 | 100 MG, 1D | 0 | 100 | MG | QD | ||||||||
| 114898234 | 11489823 | 10 | C | ARTIST | CARVEDILOL | 1 | 2.5 MG, BID | 0 | 2.5 | MG | BID | ||||||||
| 114898234 | 11489823 | 11 | C | BAYASPIRIN | ASPIRIN | 1 | 100 MG, 1D | 0 | 100 | MG | QD | ||||||||
| 114898234 | 11489823 | 12 | C | OLMETEC | OLMESARTAN MEDOXOMIL | 1 | 10 MG, 1D | 0 | 10 | MG | QD | ||||||||
| 114898234 | 11489823 | 13 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 2.5 MG, 1D | 0 | 2.5 | MG | QD | ||||||||
| 114898234 | 11489823 | 14 | C | FEBURIC | FEBUXOSTAT | 1 | 10 MG, QD | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114898234 | 11489823 | 1 | Bipolar disorder |
| 114898234 | 11489823 | 2 | Depressed mood |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114898234 | 11489823 | OT |
| 114898234 | 11489823 | HO |
| 114898234 | 11489823 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114898234 | 11489823 | Drug eruption | |
| 114898234 | 11489823 | Drug reaction with eosinophilia and systemic symptoms | |
| 114898234 | 11489823 | Pyrexia | |
| 114898234 | 11489823 | Rash | |
| 114898234 | 11489823 | Toxic epidermal necrolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114898234 | 11489823 | 1 | 20150728 | 20150810 | 0 | |
| 114898234 | 11489823 | 2 | 20150811 | 20150822 | 0 | |
| 114898234 | 11489823 | 3 | 20150801 | 0 | ||
| 114898234 | 11489823 | 4 | 20150801 | 0 |